Plays Big Boards & Biotechs! Boardmark me as I am an honest, transparent, & well respected investor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OCUL..$7.55 -was down 5% in the AH on announcement of $25M of common stock offering.
http://www.bioportfolio.com/news/article/2998365/Ocular-Therapeutix-Inc-Announces-Public-Offering-of-Common-Stock.html
$LPTX is the new ticker tomorrow for Leap Therapeutics and $MCUR. This happened because of an RM in Aug 2016. Definitely one to keep an eye on.
https://finance.yahoo.com/news/macrocure-leap-therapeutics-complete-merger-133000355.html
$ACST..$1.53..expecting news AH today so had a nice runup to this today.
$XTNT..$.356..down 18% today. Getting absolutely hammered. Similar to what we saw with $DCTH the other day in price action not as severe though. Will have to further look at this one for value. Will let the dust settle here.
$MRNS..$1.35..tremendous volume here of 26.5m shares. High as $1.87 today.
$CBIO..$.585..Corporate Present Sept 2016..http://seekingalpha.com/filings/pdf/11611236.pdf
BTX..$3.35..Biotime..Data to be shared on 1/24/16
http://www.kusi.com/story/34285616/asterias-announces-conference-call-to-discuss-6-month-efficacy-data-from-ast-opc1-scistar-study
$SGYP.. plecanatide seems to have a severe diarrhea warning similar to linzess. H/t @bio_closeau
New Economy..Alert out of $SGYP at $6.50 and $6.20 from approval. Entry was near $6.60. Big downer on approval thus far.
$SGYP FDA approves Trulance for Chronic Idiopathic Constipation http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm537725.htm
$BIOL..$1.54.. Biolase receives FDA 510(k) approval for its Epic Pro Laser. Company has not PR'ed the data yet!
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K163128
http://phx.corporate-ir.net/phoenix.zhtml?c=69766&p=irol-newsArticle&ID=2225155
$XBIO..$4.49..Shire Partnership. This one is on watch!
https://www.shire.com/research-and-development/pipeline
$XBIO Presentation: Q2 data from Shire.
http://wsw.com/webcast/ldmicro11/xbio/?lobby=true&day=2
$APHB..$.47..seems undervalued here but I need to get a better sense of their upcoming catalysts to determine the type of move this could have in the short-term.
$CFRX..$1.95..in the same position as well. Not one I have followed closely.
$BPMX..$.43..Corporate Presentation 2016
$BPMX Corporate Presentation:
http://www.biopharmx.com/wp-content/uploads/2016/12/BioPharmX-Corporate-Presentation-December-8-2016.pdf
$BPMX Fact Sheet:
http://www.biopharmx.com/wp-content/uploads/2016/12/Corporate-Fact-Sheet-December-7-2016.-1.pdf
$AVEO..$.65..Key opportunity for a potential EMA review in Q1..AVEO.. (On watch here!)http://investor.aveooncology.com/phoenix.zhtml?c=219651&p=irol-newsArticle&ID=2225774
New Economy Portfolio..buying shares in a stock that looks like the perfect catalyst mover into their April Data.
Alert..bought $BPMX at $.41..(10%) in the New Economy Portfolio. Will do more DD tonight as well!
Disclaimer:
http://bit.ly/OlN9DB